Atlantic American Corp

Aktienanalyse zu Atlantic American Corp (AAME)

$1.110

-0.020 (-1.77%)Zum Schluss

Loading chart…
Hoch
1.129
Eröffnung
1.120
Volumengewichteter Durchschnittskurs
1.11
Volumen
14.51K
Marktkap.
35.09M
Tief
1.080
Umsatz
16.06K
EV/EBITDA, TTM
0.00

Atlantic American Corporation is an insurance holding company involved, through its subsidiary companies, in specialty markets of the life, health, and property and casualty insurance industries. The Company’s principal insurance subsidiaries are American Southern Insurance Company and American Safety Insurance Company (American Southern) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (Bankers Fidelity) within the life and health insurance industry. American Southern's primary product lines include commercial automobile insurance, general liability insurance, and surety bonds. Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplements and other accident and health insurance products.

www.atlam.com

KI-Analyse of Atlantic American Corp (AAME)

Verkaufen

Atlantic American Corp (AAME) is not a good buy right now due to significant financial and compliance challenges. The stock has a current price of 1.18, which is down 59.03% year-to-date, indicating a severe decline in value. Additionally, the RSI is at a very low 18.571, suggesting that the stock is oversold, but this is not a strong enough indicator to warrant a buy. The company has also received multiple compliance notices from Nasdaq for failing to file necessary reports, which raises concerns about its operational stability. The main risk is the ongoing compliance issue, which could further impact investor confidence and stock performance.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Atlantic American Corp (AAME) beträgt 7.39, verglichen mit dem 5-Jahres-Durchschnitt von 1.16.

Erwartetes KGV

Stark überbewertet
5J-Durchschnitt P/E
1.16
Aktuelles P/E
7.39
Überbewertet
3.80
Unterbewertet
-1.48

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
0.00
Aktuelles P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio-AI-Kursszenarien für AAME

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%AAME

$2.86

Szenariopreis

B

Basis

Basis · 50%AAME

$2.63

Szenariopreis

B

Bärisch

Bärisch · 25%AAME

$2.18

Szenariopreis

AAME FAQ – beantwortet von Alphio AI

Atlantic American Corporation is an insurance holding company involved, through its subsidiary companies, in specialty markets of the life, health, and property and casualty insurance industries. The Company’s principal insurance subsidiaries are American Southern Insurance Company and American Safety Insurance Company (American Southern) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (Bankers Fidelity) within the life and health insurance industry. American Southern's primary product lines include commercial automobile insurance, general liability insurance, and surety bonds. Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplements and other accident and health insurance products. It operates in the Financials sector (LIFE INSURANCE industry).

Atlantic American Corp (AAME) is not a good buy right now due to significant financial and compliance challenges. The stock has a current price of 1.18, which is down 59.03% year-to-date, indicating a severe decline in value. Additionally, the RSI is at a very low 18.571, suggesting that the stock is oversold, but this is not a strong enough indicator to warrant a buy. The company has also received multiple compliance notices from Nasdaq for failing to file necessary reports, which raises concerns about its operational stability. The main risk is the ongoing compliance issue, which could further impact investor confidence and stock performance.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln